Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in ...

Despite the advice of two of the most successful pop anthems of the last two decades, when it comes to depression, no one can ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

Deep brain stimulation—implants in the brain that act as a kind of "pacemaker"—has led to clinical improvements in half of ...

A new study investigating neuroinflammation in the ventral tegmental area (VTA) of the brain, a small, midbrain dopaminergic ...

A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the ...

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

To provide some solid data, the authors of the new study gave LSD to a group of patients in New Zealand, and instructed them ...

Oceanside, CA – November 13, 2025 – PRESSADVANTAGE – Moment of Clarity has published a new educational resource titled “How ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

When people use ketamine for depression under medical supervision, doctors don’t consider it highly addictive. But misuse can lead to addiction. Ketamine was originally developed as an anesthetic in ...